PROVIDER PROFILE · NPI 1740568039

Oksana DavydovMD

EndocrinologyAlexandria, VAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

738

Unique beneficiaries

—

Total services

976

Distinct HCPCS

Medicare payment

$70K

Peer benchmark

Total Medicare services vs. 165 Endocrinology providers in VA — top quintile (cohort median 1,021).

PRESCRIBING · PART D · 2024

Total Rx claims

1,276

Beneficiaries

—

Total drug cost

$2.0M

Distinct drugs

Brand share

73.4%

Top prescribed drugs

Levothyroxine Sodium136 claims

Semaglutide88 claims

Levothyroxine Sodium82 claims

Empagliflozin76 claims

Insulin Glargine,hum.Rec.Anlog74 claims

QUALITY · MIPS · 2024

Final MIPS score

83.4

Quality

73.0

Cost

71.5

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.35%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Oksana Davydov's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
ST LUKES ROOSEVELT HOSPITAL CENTER	83	455
BETH ISRAEL MEDICAL CENTER	35	120
HERZOG, EYAL	18	90
Jeanine Albu Endocrinology · New York, NY	14	36
Angela Palazzo Cardiology · New York, NY	11	53

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history